Cargando…

Comparative seroprevalence of measles virus immunoglobulin M antibodies in children aged 0–8 months and a control population aged 9–23 months presenting with measles-like symptoms in selected hospitals in Kaduna State

BACKGROUND: Measles remains the leading cause of vaccine-preventable childhood mortality in developing countries, with its greatest incidence in children younger than 2 years of age. The aim of this study was to determine the seroprevalence of measles virus in children (aged 0–8 months) and older ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olaitan, AE, Ella, EE, Ameh, JB
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362903/ https://www.ncbi.nlm.nih.gov/pubmed/25792852 http://dx.doi.org/10.2147/IJGM.S79423

Ejemplares similares

Evaluation of the Measles Surveillance System in Kaduna State, Nigeria (2010-2012)
por: Ameh, Celestine A., et al.
Publicado: (2016)

Measles outbreak investigation in an urban slum of Kaduna Metropolis, Kaduna State, Nigeria, March 2015
por: Babalola, Obafemi Joseph, et al.
Publicado: (2019)

Outbreak investigation of measles in Kaduna State, Northwestern Nigeria, 2015
por: Abubakar, Aisha Ahmed, et al.
Publicado: (2018)

Determinants of pentavalent and measles vaccination dropouts among children aged 12–23 months in The Gambia
por: Ntenda, Peter A. M., et al.
Publicado: (2022)

Seroprevalence of transplacentally acquired measles antibodies in HIV-exposed versus HIV-unexposed infants at six months of age
por: Jain, Sneha, et al.
Publicado: (2017)

Seroprevalence of Transplacentally acquired Measles antibodies in unvaccinated infants at nine months of age and its relation to the feeding practices
por: Javed, Najma, et al.
Publicado: (2019)

The effect of early measles vaccination at 4.5 months of age on growth at 9 and 24 months of age in a randomized trial in Guinea-Bissau
por: Rasmussen, S. M., et al.
Publicado: (2016)

Determinants of measles vaccination dropout among 12 − 23 months aged children in pastoralist community of Afar, Ethiopia
por: Hailu, Chekole, et al.
Publicado: (2022)

Measles, mumps, and rubella vaccine at age 6 months and hospitalisation for infection before age 12 months: randomised controlled trial
por: Zimakoff, Anne Cathrine, et al.
Publicado: (2023)

Image of the month: Measles inclusion body encephalitis
por: Aldecoa, Iban, et al.
Publicado: (2020)

Proportion of children aged 9–59 months reached by the 2017 measles supplementary immunization activity among the children with or without history of measles vaccination in Lilongwe district, Malawi
por: Kainga, Hamilton Wales, et al.
Publicado: (2021)

Measles seroprevalence in persons over one year of age in Chandigarh, India
por: Mathew, Joseph L., et al.
Publicado: (2022)

Tolerability of Early Measles-Mumps-Rubella Vaccination in Infants Aged 6–14 Months During a Measles Outbreak in The Netherlands in 2013–2014
por: van der Maas, Nicoline A. T., et al.
Publicado: (2016)

Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial
por: Zaman, K., et al.
Publicado: (2016)

Spatial distribution and associated factors of measles vaccination among children aged 12–23 months in Ethiopia. A spatial and multilevel analysis
por: Tesfa, Getanew Aschalew, et al.
Publicado: (2022)

Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial
por: Aaby, Peter, et al.
Publicado: (2010)

Seroprevalence of Measles in Healthcare Workers in South Korea
por: Jung, Jiwon, et al.
Publicado: (2019)

Predictors of measles vaccination coverage among children 6–59 months of age in the Democratic Republic of the Congo
por: Ashbaugh, Hayley R., et al.
Publicado: (2018)

Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis
por: Nic Lochlainn, Laura M, et al.
Publicado: (2019)

Low titers of measles antibody in mothers whose infants suffered from measles before eligible age for measles vaccination
por: Zhao, Hong, et al.
Publicado: (2010)

Modified Measles in an Anti-Measles Immunoglobulin G-negative Healthcare Worker who had Received Two Doses of Measles-Containing Vaccine
por: Park, Jung Wan, et al.
Publicado: (2019)

Measles or Not Measles? That Is the Question!
por: Ibraheim, Marina Kristy, et al.
Publicado: (2020)

Seroprevalence of Antibodies to Measles, Mumps, and Rubella among Thai Population: Evaluation of Measles/MMR Immunization Programme
por: Tharmaphornpilas, Piyanit, et al.
Publicado: (2009)

Decreasing Seroprevalence of Measles Antibodies after Vaccination – Possible Gap in Measles Protection in Adults in the Czech Republic
por: Smetana, Jan, et al.
Publicado: (2017)

Risk factors for measles in children aged 8 months–14 years in China after nationwide measles campaign: A multi-site case-control study, 2012–2013
por: Hao, Lixin, et al.
Publicado: (2016)

Measles Seroprevalence and Related Factors in Women Aged 15–49 Years Old, in Mersin, Turkey
por: Bugdaycı Yalcın, Bengü Nehir, et al.
Publicado: (2023)

Measles Seroprevalence and Vaccine Responses in HIV-Positive Patients
por: Bieńkowski, Carlo, et al.
Publicado: (2021)

Seroprevalence of Measles and Mumps Antibodies Among Individuals With Cancer
por: Marquis, Sara R., et al.
Publicado: (2021)

Population measles seroprevalence: Heterogeneity by birth-year cohort
por: Santacruz-Sanmartin, Eduardo, et al.
Publicado: (2023)

Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau
por: Do, Vu An, et al.
Publicado: (2017)

Gap in measles vaccination coverage among children aged 9 months to 10 years in Ho Chi Minh City, Viet Nam, 2014
por: Cuong, Hoang Quoc, et al.
Publicado: (2019)

Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso
por: Sirima, Sodiomon B., et al.
Publicado: (2021)

A Randomized Trial of an Early Measles Vaccine at 4½ Months of Age in Guinea-Bissau: Sex-Differential Immunological Effects
por: Jensen, Kristoffer Jarlov, et al.
Publicado: (2014)

Risk factors for measles infection in 0–7 month old children in China after the 2010 nationwide measles campaign: A multi-site case–control study, 2012–2013
por: Ma, Chao, et al.
Publicado: (2016)

Cotreatment of Congenital Measles with Vitamin A and Intravenous Immunoglobulin
por: Ozsurekci, Yasemin, et al.
Publicado: (2014)

Seroprevalence of Measles Antibodies and Predictors for Seropositivity among Chinese Children
por: Wang, Xiaoqin, et al.
Publicado: (2017)

1076. Gaps in Measles and Mumps Seroprevalence Among Cancer Patients
por: Marquis, Sara, et al.
Publicado: (2020)

Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population
por: Quach, Huy Quang, et al.
Publicado: (2022)

Determinants of underweight among children aged 0–23 months in Tanzania
por: Moshi, Cypriana Cyprian, et al.
Publicado: (2022)

Measles antibody levels among vaccinated and unvaccinated children 6–59 months of age in the Democratic Republic of the Congo, 2013–2014
por: Ashbaugh, Hayley R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aiugbrunr0ic6mdimkhe7ag0c6